women's health
Contributed: How femtech is breaking the taboo around women’s health and closing the gender health …
Lina Chan, CEO and founder of Parla reviews femtech's roles in tackling taboo subjects in women's health and outlines the importance of involving women affected in the design process.
Fortunis Capital has awarded Clementine a place in its top 20 UK Impact Investment Fund.
The company aims to expand on third-party thermometers that can be used with its FDA cleared birth control app.
A new report from PitchBook projects solid growth in the industry, but also notes challenges in exits.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
Noting a spike in demand due to COVID-19, the company predicts that it will reach profitability by early 2021.
Berlin-based Clue, a digital health company focused on women and people with cycles, announces its first chief medical officer.
A new report published by Research2Guidance found that femtech companies have raised over $220 million since 2011. The group predicts that number will jump to $297 million by 2024.
Funding for the tech-enabled provider was led by BlueMountain Capital Management.
As part of the program two startups will each get €2 million ($2.22 million) in funding.